Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 6/2016

18.03.2016 | Original Article

Management of Primary Gastrointestinal Non-Hodgkin Lymphomas: a Population-Based Survival Analysis

verfasst von: Evan Michael Shannon, Ian T. MacQueen, Jeffrey M. Miller, Melinda Maggard-Gibbons

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Primary gastrointestinal non-Hodgkin lymphomas (PGINHL) are a heterogeneous group of rare GI malignancies with limited data to guide management. This study describes management of PGINHL in a population-based registry and aims to determine the association between receipt of surgery and long-term survival.

Methods

All adults diagnosed with PGINHL over 27 years in the Surveillance, Epidemiology, and End Results were identified (excluding mucosa-associated lymphoid tissue lymphomas). Demographic and clinical characteristics were assessed. Survival was compared using the log-rank method. Cox hazard modeling was used to determine independent prognostic factors.

Results

We identified 16,129 patients. The majority were of gastric origin and had diffuse large B cell histology. Surgery was performed in 46.9 % of patients, not recommended in 41.8 % and recommended but not performed in 10.1 %. Overall 1-year and 5-year survival rates were 65.6 and 35.6 %, respectively. Patients undergoing surgery had a 5-year survival of 43.6 % compared to 34.8 % for whom surgery was recommended but not performed (p < .0001), (receipt of chemotherapy not available). Female gender, gastric location, follicular or mantle cell histology, and radiation therapy were associated with improved survival.

Conclusions

Nearly 50 % of PGINHL patients underwent surgery. Surgery was not associated with improved survival. More prospective, case-matched studies are needed to guide management.
Literatur
1.
Zurück zum Zitat Hawkes EA, Wotherspoon A, Cunningham D. Diagnosis and management of rare gastrointestinal lymphomas. Leuk Lymphoma. Dec 2012;53(12):2341–2350. Hawkes EA, Wotherspoon A, Cunningham D. Diagnosis and management of rare gastrointestinal lymphomas. Leuk Lymphoma. Dec 2012;53(12):2341–2350.
2.
Zurück zum Zitat Dawson PJ, Harrison CV. A clinicopathological study of benign Hodgkin’s disease. J Clin Pathol. May 1961;14:219–231. Dawson PJ, Harrison CV. A clinicopathological study of benign Hodgkin’s disease. J Clin Pathol. May 1961;14:219–231.
3.
Zurück zum Zitat Al-Akwaa AM, Siddiqui N, Al-Mofleh IA. Primary gastric lymphoma. World J Gastroenterol. Jan 2004;10(1):5–11. Al-Akwaa AM, Siddiqui N, Al-Mofleh IA. Primary gastric lymphoma. World J Gastroenterol. Jan 2004;10(1):5–11.
4.
Zurück zum Zitat Ghimire P, Wu GY, Zhu L. Primary gastrointestinal lymphoma. World J Gastroenterol. Feb 14 2011;17(6):697–707. Ghimire P, Wu GY, Zhu L. Primary gastrointestinal lymphoma. World J Gastroenterol. Feb 14 2011;17(6):697–707.
5.
Zurück zum Zitat Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. Aug 1978;42(2):693–707. Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. Aug 1978;42(2):693–707.
6.
Zurück zum Zitat Cheung MC, Housri N, Ogilvie MP, Sola JE, Koniaris LG. Surgery does not adversely affect survival in primary gastrointestinal lymphoma. J Surg Oncol. Jul 1 2009;100(1):59–64. Cheung MC, Housri N, Ogilvie MP, Sola JE, Koniaris LG. Surgery does not adversely affect survival in primary gastrointestinal lymphoma. J Surg Oncol. Jul 1 2009;100(1):59–64.
7.
Zurück zum Zitat Gurney KA, Cartwright RA. Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. Hematol J. 2002;3(2):95–104.CrossRefPubMed Gurney KA, Cartwright RA. Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. Hematol J. 2002;3(2):95–104.CrossRefPubMed
8.
Zurück zum Zitat Halme L, Mecklin JP, Juhola M, Krees R, Palmu A. Primary gastrointestinal non-Hodgkin’s lymphoma. A population based study in central Finland in 1975–1993. Acta oncologica. 1997;36(1):69–74.CrossRefPubMed Halme L, Mecklin JP, Juhola M, Krees R, Palmu A. Primary gastrointestinal non-Hodgkin’s lymphoma. A population based study in central Finland in 1975–1993. Acta oncologica. 1997;36(1):69–74.CrossRefPubMed
9.
Zurück zum Zitat Stathis A, Chini C, Bertoni F, et al. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol. Jun 2009;20(6):1086–1093. Stathis A, Chini C, Bertoni F, et al. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol. Jun 2009;20(6):1086–1093.
10.
Zurück zum Zitat Stolte M, Bayerdorffer E, Morgner A, et al. Helicobacter and gastric MALT lymphoma. Gut. May 2002;50 Suppl 3:III19-24. Stolte M, Bayerdorffer E, Morgner A, et al. Helicobacter and gastric MALT lymphoma. Gut. May 2002;50 Suppl 3:III19-24.
11.
Zurück zum Zitat Atalay C, Kanlioz M, Demir S, Pak I, Altinok M. Primary gastrointestinal tract lymphomas. Acta chirurgica Belgica. Nov-Dec 2003;103(6):616–620. Atalay C, Kanlioz M, Demir S, Pak I, Altinok M. Primary gastrointestinal tract lymphomas. Acta chirurgica Belgica. Nov-Dec 2003;103(6):616–620.
12.
Zurück zum Zitat Fischbach W, Dragosics B, Kolve-Goebeler ME, et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterol. Nov 2000;119(5):1191–1202. Fischbach W, Dragosics B, Kolve-Goebeler ME, et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterol. Nov 2000;119(5):1191–1202.
13.
Zurück zum Zitat Daum S, Ullrich R, Heise W, et al. Intestinal non-Hodgkin’s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s Lymphoma. J Clin Oncol. Jul 15 2003;21(14):2740–2746. Daum S, Ullrich R, Heise W, et al. Intestinal non-Hodgkin’s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s Lymphoma. J Clin Oncol. Jul 15 2003;21(14):2740–2746.
14.
Zurück zum Zitat Erkurt MA, Aydogdu I, Kuku I, Kaya E, Mizrak B, Basaran Y. A multicentric, hyaline vascular variant of Castleman’s disease associated with B cell lymphoma: a case report. Cases J. 2009;2:8183.CrossRefPubMedPubMedCentral Erkurt MA, Aydogdu I, Kuku I, Kaya E, Mizrak B, Basaran Y. A multicentric, hyaline vascular variant of Castleman’s disease associated with B cell lymphoma: a case report. Cases J. 2009;2:8183.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Eser B, Kaplan B, Unal A, et al. Clinicopathologic characteristics and therapeutic outcomes of primary gastrointestinal non-Hodgkin’s lymphomas in central Anatolia, in Turkey. Yonsei Med J. Feb 28 2006;47(1):22–33. Eser B, Kaplan B, Unal A, et al. Clinicopathologic characteristics and therapeutic outcomes of primary gastrointestinal non-Hodgkin’s lymphomas in central Anatolia, in Turkey. Yonsei Med J. Feb 28 2006;47(1):22–33.
16.
Zurück zum Zitat Kim SJ, Kang HJ, Kim JS, et al. Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. Blood. Feb 10 2011;117(6):1958–1965. Kim SJ, Kang HJ, Kim JS, et al. Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. Blood. Feb 10 2011;117(6):1958–1965.
17.
Zurück zum Zitat Lai YL, Lin JK, Liang WY, Huang YC, Chang SC. Surgical resection combined with chemotherapy can help achieve better outcomes in patients with primary colonic lymphoma. J Surg Oncol. Sep 1 2011;104(3):265–268. Lai YL, Lin JK, Liang WY, Huang YC, Chang SC. Surgical resection combined with chemotherapy can help achieve better outcomes in patients with primary colonic lymphoma. J Surg Oncol. Sep 1 2011;104(3):265–268.
18.
Zurück zum Zitat Lee HS, Park LC, Lee EM, et al. Comparison of Therapeutic Outcomes Between Surgical Resection Followed By R-CHOP and R-CHOP Alone for Localized Primary Intestinal Diffuse Large B-cell Lymphoma. Am J Clin Oncol. Dec 1 2012. Lee HS, Park LC, Lee EM, et al. Comparison of Therapeutic Outcomes Between Surgical Resection Followed By R-CHOP and R-CHOP Alone for Localized Primary Intestinal Diffuse Large B-cell Lymphoma. Am J Clin Oncol. Dec 1 2012.
19.
Zurück zum Zitat Tang TC, Kuo MC, Chang H, et al. Primary colonic lymphoma: an analysis of 74 cases with localized large-cell lymphoma. Eur J Haematol. Jul 2011;87(1):28–36. Tang TC, Kuo MC, Chang H, et al. Primary colonic lymphoma: an analysis of 74 cases with localized large-cell lymphoma. Eur J Haematol. Jul 2011;87(1):28–36.
20.
Zurück zum Zitat Cirocchi R, Farinella E, Trastulli S, et al. Surgical treatment of primitive gastro-intestinal lymphomas: a systematic review. World J Surg Oncol. 2011;9:145.CrossRefPubMedPubMedCentral Cirocchi R, Farinella E, Trastulli S, et al. Surgical treatment of primitive gastro-intestinal lymphomas: a systematic review. World J Surg Oncol. 2011;9:145.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Fischbach W, Schramm S, Goebeler E. Outcome and quality of life favour a conservative treatment of patients with primary gastric lymphoma. Zeitschrift fur Gastroenterologie. Apr 2011;49(4):430–435. Fischbach W, Schramm S, Goebeler E. Outcome and quality of life favour a conservative treatment of patients with primary gastric lymphoma. Zeitschrift fur Gastroenterologie. Apr 2011;49(4):430–435.
22.
Zurück zum Zitat Willich NA, Reinartz G, Horst EJ, et al. Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study. Int J Radiat Oncol Biol Phys. Mar 1 2000;46(4):895–901. Willich NA, Reinartz G, Horst EJ, et al. Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study. Int J Radiat Oncol Biol Phys. Mar 1 2000;46(4):895–901.
23.
Zurück zum Zitat Aviles A, Nambo MJ, Neri N, et al. The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Annals of surgery. Jul 2004;240(1):44–50. Aviles A, Nambo MJ, Neri N, et al. The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Annals of surgery. Jul 2004;240(1):44–50.
24.
Zurück zum Zitat Beaton C, Davies M, Beynon J. The management of primary small bowel and colon lymphoma--a review. Int J Colorectal Dis. May 2012;27(5):555–563. Beaton C, Davies M, Beynon J. The management of primary small bowel and colon lymphoma--a review. Int J Colorectal Dis. May 2012;27(5):555–563.
25.
Zurück zum Zitat Kim SJ, Choi CW, Mun YC, et al. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL). BMC cancer. 2011;11:321.CrossRefPubMedPubMedCentral Kim SJ, Choi CW, Mun YC, et al. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL). BMC cancer. 2011;11:321.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Lee J, Kim WS, Kim K, et al. Intestinal Lymphoma: Exploration of the Prognostic Factors and the Optimal Treatment. Leuk lymphoma. 2004;45(2):339–344.CrossRefPubMed Lee J, Kim WS, Kim K, et al. Intestinal Lymphoma: Exploration of the Prognostic Factors and the Optimal Treatment. Leuk lymphoma. 2004;45(2):339–344.CrossRefPubMed
27.
Zurück zum Zitat Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database. Am J Hematol. Mar 2014;89(3):310–314. Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database. Am J Hematol. Mar 2014;89(3):310–314.
28.
Zurück zum Zitat Kassira N, Pedroso FE, Cheung MC, Koniaris LG, Sola JE. Primary gastrointestinal tract lymphoma in the pediatric patient: review of 265 patients from the SEER registry. J Pediatr Surg. Oct 2011;46(10):1956–1964. Kassira N, Pedroso FE, Cheung MC, Koniaris LG, Sola JE. Primary gastrointestinal tract lymphoma in the pediatric patient: review of 265 patients from the SEER registry. J Pediatr Surg. Oct 2011;46(10):1956–1964.
29.
Zurück zum Zitat Shchepotin IB, Evans SR, Shabahang M, et al. Primary non-Hodgkin’s lymphoma of the stomach: three radical modalities of treatment in 75 patients. Ann Surg Oncol. May 1996;3(3):277–284. Shchepotin IB, Evans SR, Shabahang M, et al. Primary non-Hodgkin’s lymphoma of the stomach: three radical modalities of treatment in 75 patients. Ann Surg Oncol. May 1996;3(3):277–284.
30.
Zurück zum Zitat Ambinder AJ, Shenoy PJ, Nastoupil LJ, Flowers CR. Using primary site as a predictor of survival in mantle cell lymphoma. Cancer. Apr 15 2013;119(8):1570–1577. Ambinder AJ, Shenoy PJ, Nastoupil LJ, Flowers CR. Using primary site as a predictor of survival in mantle cell lymphoma. Cancer. Apr 15 2013;119(8):1570–1577.
31.
Zurück zum Zitat Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. May 12 2011;117(19):5019–5032. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. May 12 2011;117(19):5019–5032.
32.
Zurück zum Zitat Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. New Engl J Med. Jan 24 2002;346(4):235–242. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. New Engl J Med. Jan 24 2002;346(4):235–242.
33.
Zurück zum Zitat Plosker GL, Figgitt DP. Rituximab: a review of its use in non-Hodgkin’s lymphoma and chronic lymphocytic leukaemia. Drugs. 2003;63(8):803–843.CrossRefPubMed Plosker GL, Figgitt DP. Rituximab: a review of its use in non-Hodgkin’s lymphoma and chronic lymphocytic leukaemia. Drugs. 2003;63(8):803–843.CrossRefPubMed
34.
Zurück zum Zitat Hermans J, Krol AD, van Groningen K, et al. International Prognostic Index for aggressive non-Hodgkin’s lymphoma is valid for all malignancy grades. Blood. Aug 15 1995;86(4):1460–1463. Hermans J, Krol AD, van Groningen K, et al. International Prognostic Index for aggressive non-Hodgkin’s lymphoma is valid for all malignancy grades. Blood. Aug 15 1995;86(4):1460–1463.
35.
Zurück zum Zitat A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. New Engl J Med. Sep 30 1993;329(14):987–994. A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. New Engl J Med. Sep 30 1993;329(14):987–994.
Metadaten
Titel
Management of Primary Gastrointestinal Non-Hodgkin Lymphomas: a Population-Based Survival Analysis
verfasst von
Evan Michael Shannon
Ian T. MacQueen
Jeffrey M. Miller
Melinda Maggard-Gibbons
Publikationsdatum
18.03.2016
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 6/2016
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-016-3129-8

Weitere Artikel der Ausgabe 6/2016

Journal of Gastrointestinal Surgery 6/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.